Can B Corp.
Can B Corp. CANB Peers
See (CANB) competitors and their performances in Stock Market.
Peer Comparison Table: Drug Manufacturers - Specialty & Generic Industry
Detailed financial metrics including price, market cap, P/E ratio, and more.
| Symbol | Price | Change % | Market Cap | P/E Ratio | EPS | Dividend Yield |
|---|---|---|---|---|---|---|
| CANB | $0.03 | +4.35% | 2.37M | 0.35 | $0.09 | N/A |
| MKGAF | $130.48 | -4.20% | 56.73B | 18.00 | $7.25 | +1.70% |
| MKKGY | $26.57 | +0.46% | 56.18B | 18.32 | $1.45 | +1.44% |
| HLNCF | $5.55 | +1.09% | 50.06B | 27.75 | $0.20 | +1.94% |
| TKPHF | $26.30 | -18.15% | 41.39B | 57.17 | $0.46 | +5.06% |
| IPSEY | $29.24 | -0.34% | 38.69B | 24.57 | $1.19 | +1.07% |
| SDZNY | $48.49 | +0.77% | 20.88B | -2424.50 | -$0.02 | +0.84% |
| TEVJF | $16.11 | N/A | 18.46B | -14.01 | -$1.15 | N/A |
| ESALY | $61.51 | -2.11% | 17.64B | 20.54 | $3.00 | N/A |
| SGIOY | $7.99 | +1.85% | 13.59B | 11.58 | $0.69 | +0.88% |
Stock Comparison
CANB vs MKGAF Comparison
CANB plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, CANB stands at 2.37M. In comparison, MKGAF has a market cap of 56.73B. Regarding current trading prices, CANB is priced at $0.03, while MKGAF trades at $130.48.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
CANB currently has a P/E ratio of 0.35, whereas MKGAF's P/E ratio is 18.00. In terms of profitability, CANB's ROE is +2.20%, compared to MKGAF's ROE of +0.10%. Regarding short-term risk, CANB is more volatile compared to MKGAF. This indicates potentially higher risk in terms of short-term price fluctuations for CANB.
CANB vs MKKGY Comparison
CANB plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, CANB stands at 2.37M. In comparison, MKKGY has a market cap of 56.18B. Regarding current trading prices, CANB is priced at $0.03, while MKKGY trades at $26.57.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
CANB currently has a P/E ratio of 0.35, whereas MKKGY's P/E ratio is 18.32. In terms of profitability, CANB's ROE is +2.20%, compared to MKKGY's ROE of +0.10%. Regarding short-term risk, CANB is more volatile compared to MKKGY. This indicates potentially higher risk in terms of short-term price fluctuations for CANB.
CANB vs HLNCF Comparison
CANB plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, CANB stands at 2.37M. In comparison, HLNCF has a market cap of 50.06B. Regarding current trading prices, CANB is priced at $0.03, while HLNCF trades at $5.55.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
CANB currently has a P/E ratio of 0.35, whereas HLNCF's P/E ratio is 27.75. In terms of profitability, CANB's ROE is +2.20%, compared to HLNCF's ROE of +0.09%. Regarding short-term risk, CANB is more volatile compared to HLNCF. This indicates potentially higher risk in terms of short-term price fluctuations for CANB.
CANB vs TKPHF Comparison
CANB plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, CANB stands at 2.37M. In comparison, TKPHF has a market cap of 41.39B. Regarding current trading prices, CANB is priced at $0.03, while TKPHF trades at $26.30.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
CANB currently has a P/E ratio of 0.35, whereas TKPHF's P/E ratio is 57.17. In terms of profitability, CANB's ROE is +2.20%, compared to TKPHF's ROE of +0.03%. Regarding short-term risk, CANB is less volatile compared to TKPHF. This indicates potentially lower risk in terms of short-term price fluctuations for CANB.
CANB vs IPSEY Comparison
CANB plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, CANB stands at 2.37M. In comparison, IPSEY has a market cap of 38.69B. Regarding current trading prices, CANB is priced at $0.03, while IPSEY trades at $29.24.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
CANB currently has a P/E ratio of 0.35, whereas IPSEY's P/E ratio is 24.57. In terms of profitability, CANB's ROE is +2.20%, compared to IPSEY's ROE of +0.17%. Regarding short-term risk, CANB is more volatile compared to IPSEY. This indicates potentially higher risk in terms of short-term price fluctuations for CANB.
CANB vs SDZNY Comparison
CANB plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, CANB stands at 2.37M. In comparison, SDZNY has a market cap of 20.88B. Regarding current trading prices, CANB is priced at $0.03, while SDZNY trades at $48.49.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
CANB currently has a P/E ratio of 0.35, whereas SDZNY's P/E ratio is -2424.50. In terms of profitability, CANB's ROE is +2.20%, compared to SDZNY's ROE of +0.00%. Regarding short-term risk, CANB is more volatile compared to SDZNY. This indicates potentially higher risk in terms of short-term price fluctuations for CANB.
CANB vs TEVJF Comparison
CANB plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, CANB stands at 2.37M. In comparison, TEVJF has a market cap of 18.46B. Regarding current trading prices, CANB is priced at $0.03, while TEVJF trades at $16.11.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
CANB currently has a P/E ratio of 0.35, whereas TEVJF's P/E ratio is -14.01. In terms of profitability, CANB's ROE is +2.20%, compared to TEVJF's ROE of -0.21%. Regarding short-term risk, CANB is more volatile compared to TEVJF. This indicates potentially higher risk in terms of short-term price fluctuations for CANB.
CANB vs ESALY Comparison
CANB plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, CANB stands at 2.37M. In comparison, ESALY has a market cap of 17.64B. Regarding current trading prices, CANB is priced at $0.03, while ESALY trades at $61.51.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
CANB currently has a P/E ratio of 0.35, whereas ESALY's P/E ratio is 20.54. In terms of profitability, CANB's ROE is +2.20%, compared to ESALY's ROE of +0.06%. Regarding short-term risk, CANB is more volatile compared to ESALY. This indicates potentially higher risk in terms of short-term price fluctuations for CANB.
CANB vs SGIOY Comparison
CANB plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, CANB stands at 2.37M. In comparison, SGIOY has a market cap of 13.59B. Regarding current trading prices, CANB is priced at $0.03, while SGIOY trades at $7.99.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
CANB currently has a P/E ratio of 0.35, whereas SGIOY's P/E ratio is 11.58. In terms of profitability, CANB's ROE is +2.20%, compared to SGIOY's ROE of +0.08%. Regarding short-term risk, CANB is more volatile compared to SGIOY. This indicates potentially higher risk in terms of short-term price fluctuations for CANB.
CANB vs SGIOF Comparison
CANB plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, CANB stands at 2.37M. In comparison, SGIOF has a market cap of 12.93B. Regarding current trading prices, CANB is priced at $0.03, while SGIOF trades at $15.20.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
CANB currently has a P/E ratio of 0.35, whereas SGIOF's P/E ratio is 11.09. In terms of profitability, CANB's ROE is +2.20%, compared to SGIOF's ROE of +0.08%. Regarding short-term risk, CANB is more volatile compared to SGIOF. This indicates potentially higher risk in terms of short-term price fluctuations for CANB.
CANB vs BIOVF Comparison
CANB plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, CANB stands at 2.37M. In comparison, BIOVF has a market cap of 10.48B. Regarding current trading prices, CANB is priced at $0.03, while BIOVF trades at $30.50.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
CANB currently has a P/E ratio of 0.35, whereas BIOVF's P/E ratio is 26.07. In terms of profitability, CANB's ROE is +2.20%, compared to BIOVF's ROE of +0.10%. Regarding short-term risk, CANB is less volatile compared to BIOVF. This indicates potentially lower risk in terms of short-term price fluctuations for CANB.
CANB vs IPSEF Comparison
CANB plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, CANB stands at 2.37M. In comparison, IPSEF has a market cap of 10.37B. Regarding current trading prices, CANB is priced at $0.03, while IPSEF trades at $125.37.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
CANB currently has a P/E ratio of 0.35, whereas IPSEF's P/E ratio is 25.96. In terms of profitability, CANB's ROE is +2.20%, compared to IPSEF's ROE of +0.14%. Regarding short-term risk, CANB is less volatile compared to IPSEF. This indicates potentially lower risk in terms of short-term price fluctuations for CANB.
CANB vs SFOSF Comparison
CANB plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, CANB stands at 2.37M. In comparison, SFOSF has a market cap of 8.76B. Regarding current trading prices, CANB is priced at $0.03, while SFOSF trades at $1.97.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
CANB currently has a P/E ratio of 0.35, whereas SFOSF's P/E ratio is 13.13. In terms of profitability, CANB's ROE is +2.20%, compared to SFOSF's ROE of +0.06%. Regarding short-term risk, CANB is less volatile compared to SFOSF. This indicates potentially lower risk in terms of short-term price fluctuations for CANB.
CANB vs ESAIY Comparison
CANB plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, CANB stands at 2.37M. In comparison, ESAIY has a market cap of 7.72B. Regarding current trading prices, CANB is priced at $0.03, while ESAIY trades at $6.81.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
CANB currently has a P/E ratio of 0.35, whereas ESAIY's P/E ratio is 24.32. In terms of profitability, CANB's ROE is +2.20%, compared to ESAIY's ROE of +0.03%. Regarding short-term risk, CANB is more volatile compared to ESAIY. This indicates potentially higher risk in terms of short-term price fluctuations for CANB.
CANB vs ESALF Comparison
CANB plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, CANB stands at 2.37M. In comparison, ESALF has a market cap of 7.62B. Regarding current trading prices, CANB is priced at $0.03, while ESALF trades at $27.00.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
CANB currently has a P/E ratio of 0.35, whereas ESALF's P/E ratio is 23.89. In terms of profitability, CANB's ROE is +2.20%, compared to ESALF's ROE of +0.03%. Regarding short-term risk, CANB is more volatile compared to ESALF. This indicates potentially higher risk in terms of short-term price fluctuations for CANB.
CANB vs GZPHF Comparison
CANB plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, CANB stands at 2.37M. In comparison, GZPHF has a market cap of 6.30B. Regarding current trading prices, CANB is priced at $0.03, while GZPHF trades at $2.44.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
CANB currently has a P/E ratio of 0.35, whereas GZPHF's P/E ratio is 10.61. In terms of profitability, CANB's ROE is +2.20%, compared to GZPHF's ROE of +0.07%. Regarding short-term risk, CANB is more volatile compared to GZPHF. This indicates potentially higher risk in terms of short-term price fluctuations for CANB.
CANB vs HKMPY Comparison
CANB plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, CANB stands at 2.37M. In comparison, HKMPY has a market cap of 6.18B. Regarding current trading prices, CANB is priced at $0.03, while HKMPY trades at $56.07.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
CANB currently has a P/E ratio of 0.35, whereas HKMPY's P/E ratio is 17.41. In terms of profitability, CANB's ROE is +2.20%, compared to HKMPY's ROE of +0.16%. Regarding short-term risk, CANB is more volatile compared to HKMPY. This indicates potentially higher risk in terms of short-term price fluctuations for CANB.
CANB vs HKMPF Comparison
CANB plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, CANB stands at 2.37M. In comparison, HKMPF has a market cap of 6.11B. Regarding current trading prices, CANB is priced at $0.03, while HKMPF trades at $27.73.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
CANB currently has a P/E ratio of 0.35, whereas HKMPF's P/E ratio is 17.22. In terms of profitability, CANB's ROE is +2.20%, compared to HKMPF's ROE of +0.16%. Regarding short-term risk, CANB is more volatile compared to HKMPF. This indicates potentially higher risk in terms of short-term price fluctuations for CANB.
CANB vs APNHF Comparison
CANB plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, CANB stands at 2.37M. In comparison, APNHF has a market cap of 5.44B. Regarding current trading prices, CANB is priced at $0.03, while APNHF trades at $12.25.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
CANB currently has a P/E ratio of 0.35, whereas APNHF's P/E ratio is 20.07. In terms of profitability, CANB's ROE is +2.20%, compared to APNHF's ROE of +0.04%. Regarding short-term risk, CANB is more volatile compared to APNHF. This indicates potentially higher risk in terms of short-term price fluctuations for CANB.
CANB vs WIBFF Comparison
CANB plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, CANB stands at 2.37M. In comparison, WIBFF has a market cap of 4.93B. Regarding current trading prices, CANB is priced at $0.03, while WIBFF trades at $0.00.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
CANB currently has a P/E ratio of 0.35, whereas WIBFF's P/E ratio is -0.01. In terms of profitability, CANB's ROE is +2.20%, compared to WIBFF's ROE of +0.00%. Regarding short-term risk, CANB is less volatile compared to WIBFF. This indicates potentially lower risk in terms of short-term price fluctuations for CANB.
CANB vs HLBBF Comparison
CANB plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, CANB stands at 2.37M. In comparison, HLBBF has a market cap of 4.46B. Regarding current trading prices, CANB is priced at $0.03, while HLBBF trades at $5.63.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
CANB currently has a P/E ratio of 0.35, whereas HLBBF's P/E ratio is 11.72. In terms of profitability, CANB's ROE is +2.20%, compared to HLBBF's ROE of +0.13%. Regarding short-term risk, CANB is more volatile compared to HLBBF. This indicates potentially higher risk in terms of short-term price fluctuations for CANB.
CANB vs LVZPF Comparison
CANB plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, CANB stands at 2.37M. In comparison, LVZPF has a market cap of 3.99B. Regarding current trading prices, CANB is priced at $0.03, while LVZPF trades at $3.43.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
CANB currently has a P/E ratio of 0.35, whereas LVZPF's P/E ratio is 11.43. In terms of profitability, CANB's ROE is +2.20%, compared to LVZPF's ROE of +0.15%. Regarding short-term risk, CANB is more volatile compared to LVZPF. This indicates potentially higher risk in terms of short-term price fluctuations for CANB.
CANB vs HLUBF Comparison
CANB plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, CANB stands at 2.37M. In comparison, HLUBF has a market cap of 3.50B. Regarding current trading prices, CANB is priced at $0.03, while HLUBF trades at $3.70.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
CANB currently has a P/E ratio of 0.35, whereas HLUBF's P/E ratio is 7.71. In terms of profitability, CANB's ROE is +2.20%, compared to HLUBF's ROE of +0.13%. Regarding short-term risk, CANB is less volatile compared to HLUBF. This indicates potentially lower risk in terms of short-term price fluctuations for CANB.
CANB vs INVVY Comparison
CANB plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, CANB stands at 2.37M. In comparison, INVVY has a market cap of 3.01B. Regarding current trading prices, CANB is priced at $0.03, while INVVY trades at $21.85.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
CANB currently has a P/E ratio of 0.35, whereas INVVY's P/E ratio is -62.42. In terms of profitability, CANB's ROE is +2.20%, compared to INVVY's ROE of -0.01%. Regarding short-term risk, CANB is more volatile compared to INVVY. This indicates potentially higher risk in terms of short-term price fluctuations for CANB.
CANB vs APNHY Comparison
CANB plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, CANB stands at 2.37M. In comparison, APNHY has a market cap of 2.93B. Regarding current trading prices, CANB is priced at $0.03, while APNHY trades at $6.60.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
CANB currently has a P/E ratio of 0.35, whereas APNHY's P/E ratio is 11.79. In terms of profitability, CANB's ROE is +2.20%, compared to APNHY's ROE of +0.05%. Regarding short-term risk, CANB is more volatile compared to APNHY. This indicates potentially higher risk in terms of short-term price fluctuations for CANB.
CANB vs IZQVF Comparison
CANB plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, CANB stands at 2.37M. In comparison, IZQVF has a market cap of 2.89B. Regarding current trading prices, CANB is priced at $0.03, while IZQVF trades at $20.97.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
CANB currently has a P/E ratio of 0.35, whereas IZQVF's P/E ratio is -56.68. In terms of profitability, CANB's ROE is +2.20%, compared to IZQVF's ROE of -0.01%. Regarding short-term risk, CANB is more volatile compared to IZQVF. This indicates potentially higher risk in terms of short-term price fluctuations for CANB.
CANB vs HMDCF Comparison
CANB plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, CANB stands at 2.37M. In comparison, HMDCF has a market cap of 2.79B. Regarding current trading prices, CANB is priced at $0.03, while HMDCF trades at $3.21.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
CANB currently has a P/E ratio of 0.35, whereas HMDCF's P/E ratio is -64.10. In terms of profitability, CANB's ROE is +2.20%, compared to HMDCF's ROE of -0.01%. Regarding short-term risk, CANB is less volatile compared to HMDCF. This indicates potentially lower risk in terms of short-term price fluctuations for CANB.
CANB vs HYPMY Comparison
CANB plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, CANB stands at 2.37M. In comparison, HYPMY has a market cap of 2.69B. Regarding current trading prices, CANB is priced at $0.03, while HYPMY trades at $4.27.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
CANB currently has a P/E ratio of 0.35, whereas HYPMY's P/E ratio is 19.39. In terms of profitability, CANB's ROE is +2.20%, compared to HYPMY's ROE of +0.07%. Regarding short-term risk, CANB is more volatile compared to HYPMY. This indicates potentially higher risk in terms of short-term price fluctuations for CANB.
CANB vs DNPUF Comparison
CANB plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, CANB stands at 2.37M. In comparison, DNPUF has a market cap of 2.59B. Regarding current trading prices, CANB is priced at $0.03, while DNPUF trades at $6.53.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
CANB currently has a P/E ratio of 0.35, whereas DNPUF's P/E ratio is 15.93. In terms of profitability, CANB's ROE is +2.20%, compared to DNPUF's ROE of -1.05%. Regarding short-term risk, CANB is less volatile compared to DNPUF. This indicates potentially lower risk in terms of short-term price fluctuations for CANB.
CANB vs ULIHF Comparison
CANB plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, CANB stands at 2.37M. In comparison, ULIHF has a market cap of 2.54B. Regarding current trading prices, CANB is priced at $0.03, while ULIHF trades at $1.40.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
CANB currently has a P/E ratio of 0.35, whereas ULIHF's P/E ratio is 7.00. In terms of profitability, CANB's ROE is +2.20%, compared to ULIHF's ROE of +0.21%. Regarding short-term risk, CANB is more volatile compared to ULIHF. This indicates potentially higher risk in terms of short-term price fluctuations for CANB.
CANB vs HTSUF Comparison
CANB plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, CANB stands at 2.37M. In comparison, HTSUF has a market cap of 2.36B. Regarding current trading prices, CANB is priced at $0.03, while HTSUF trades at $32.30.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
CANB currently has a P/E ratio of 0.35, whereas HTSUF's P/E ratio is 15.91. In terms of profitability, CANB's ROE is +2.20%, compared to HTSUF's ROE of +0.05%. Regarding short-term risk, CANB is more volatile compared to HTSUF. This indicates potentially higher risk in terms of short-term price fluctuations for CANB.
CANB vs THCBF Comparison
CANB plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, CANB stands at 2.37M. In comparison, THCBF has a market cap of 2.35B. Regarding current trading prices, CANB is priced at $0.03, while THCBF trades at $0.00.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
CANB currently has a P/E ratio of 0.35, whereas THCBF's P/E ratio is -0.10. In terms of profitability, CANB's ROE is +2.20%, compared to THCBF's ROE of +0.00%. Regarding short-term risk, CANB is less volatile compared to THCBF. This indicates potentially lower risk in terms of short-term price fluctuations for CANB.
CANB vs CHSYF Comparison
CANB plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, CANB stands at 2.37M. In comparison, CHSYF has a market cap of 2.25B. Regarding current trading prices, CANB is priced at $0.03, while CHSYF trades at $0.93.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
CANB currently has a P/E ratio of 0.35, whereas CHSYF's P/E ratio is 6.65. In terms of profitability, CANB's ROE is +2.20%, compared to CHSYF's ROE of +0.09%. Regarding short-term risk, CANB is more volatile compared to CHSYF. This indicates potentially higher risk in terms of short-term price fluctuations for CANB.
CANB vs TSMRF Comparison
CANB plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, CANB stands at 2.37M. In comparison, TSMRF has a market cap of 2.13B. Regarding current trading prices, CANB is priced at $0.03, while TSMRF trades at $28.15.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
CANB currently has a P/E ratio of 0.35, whereas TSMRF's P/E ratio is 13.03. In terms of profitability, CANB's ROE is +2.20%, compared to TSMRF's ROE of +0.07%. Regarding short-term risk, CANB is more volatile compared to TSMRF. This indicates potentially higher risk in terms of short-term price fluctuations for CANB.
CANB vs DMPHF Comparison
CANB plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, CANB stands at 2.37M. In comparison, DMPHF has a market cap of 2.13B. Regarding current trading prices, CANB is priced at $0.03, while DMPHF trades at $39.56.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
CANB currently has a P/E ratio of 0.35, whereas DMPHF's P/E ratio is 18.40. In terms of profitability, CANB's ROE is +2.20%, compared to DMPHF's ROE of +0.20%. Regarding short-term risk, CANB is more volatile compared to DMPHF. This indicates potentially higher risk in terms of short-term price fluctuations for CANB.
CANB vs LJUIF Comparison
CANB plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, CANB stands at 2.37M. In comparison, LJUIF has a market cap of 2.06B. Regarding current trading prices, CANB is priced at $0.03, while LJUIF trades at $0.70.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
CANB currently has a P/E ratio of 0.35, whereas LJUIF's P/E ratio is 13.97. In terms of profitability, CANB's ROE is +2.20%, compared to LJUIF's ROE of +0.19%. Regarding short-term risk, CANB is more volatile compared to LJUIF. This indicates potentially higher risk in terms of short-term price fluctuations for CANB.
CANB vs LBTSF Comparison
CANB plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, CANB stands at 2.37M. In comparison, LBTSF has a market cap of 1.92B. Regarding current trading prices, CANB is priced at $0.03, while LBTSF trades at $9.01.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
CANB currently has a P/E ratio of 0.35, whereas LBTSF's P/E ratio is 150.17. In terms of profitability, CANB's ROE is +2.20%, compared to LBTSF's ROE of +0.01%. Regarding short-term risk, CANB is more volatile compared to LBTSF. This indicates potentially higher risk in terms of short-term price fluctuations for CANB.
CANB vs CHIZF Comparison
CANB plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, CANB stands at 2.37M. In comparison, CHIZF has a market cap of 1.69B. Regarding current trading prices, CANB is priced at $0.03, while CHIZF trades at $0.34.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
CANB currently has a P/E ratio of 0.35, whereas CHIZF's P/E ratio is 16.80. In terms of profitability, CANB's ROE is +2.20%, compared to CHIZF's ROE of +0.04%. Regarding short-term risk, CANB is more volatile compared to CHIZF. This indicates potentially higher risk in terms of short-term price fluctuations for CANB.
CANB vs SHEZF Comparison
CANB plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, CANB stands at 2.37M. In comparison, SHEZF has a market cap of 1.66B. Regarding current trading prices, CANB is priced at $0.03, while SHEZF trades at $0.47.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
CANB currently has a P/E ratio of 0.35, whereas SHEZF's P/E ratio is -23.48. In terms of profitability, CANB's ROE is +2.20%, compared to SHEZF's ROE of +0.05%. Regarding short-term risk, CANB is less volatile compared to SHEZF. This indicates potentially lower risk in terms of short-term price fluctuations for CANB.
CANB vs SMDPY Comparison
CANB plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, CANB stands at 2.37M. In comparison, SMDPY has a market cap of 1.63B. Regarding current trading prices, CANB is priced at $0.03, while SMDPY trades at $4.10.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
CANB currently has a P/E ratio of 0.35, whereas SMDPY's P/E ratio is -1.35. In terms of profitability, CANB's ROE is +2.20%, compared to SMDPY's ROE of -1.44%. Regarding short-term risk, CANB is more volatile compared to SMDPY. This indicates potentially higher risk in terms of short-term price fluctuations for CANB.
CANB vs NPNKF Comparison
CANB plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, CANB stands at 2.37M. In comparison, NPNKF has a market cap of 1.59B. Regarding current trading prices, CANB is priced at $0.03, while NPNKF trades at $23.58.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
CANB currently has a P/E ratio of 0.35, whereas NPNKF's P/E ratio is 7.10. In terms of profitability, CANB's ROE is +2.20%, compared to NPNKF's ROE of +0.09%. Regarding short-term risk, CANB is less volatile compared to NPNKF. This indicates potentially lower risk in terms of short-term price fluctuations for CANB.
CANB vs NPPNY Comparison
CANB plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, CANB stands at 2.37M. In comparison, NPPNY has a market cap of 1.54B. Regarding current trading prices, CANB is priced at $0.03, while NPPNY trades at $5.72.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
CANB currently has a P/E ratio of 0.35, whereas NPPNY's P/E ratio is 6.89. In terms of profitability, CANB's ROE is +2.20%, compared to NPPNY's ROE of +0.09%. Regarding short-term risk, CANB is less volatile compared to NPPNY. This indicates potentially lower risk in terms of short-term price fluctuations for CANB.
CANB vs KARBF Comparison
CANB plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, CANB stands at 2.37M. In comparison, KARBF has a market cap of 1.52B. Regarding current trading prices, CANB is priced at $0.03, while KARBF trades at $5.25.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
CANB currently has a P/E ratio of 0.35, whereas KARBF's P/E ratio is 262.50. In terms of profitability, CANB's ROE is +2.20%, compared to KARBF's ROE of N/A. Regarding short-term risk, CANB is more volatile compared to KARBF. This indicates potentially higher risk in terms of short-term price fluctuations for CANB.
CANB vs YIHCF Comparison
CANB plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, CANB stands at 2.37M. In comparison, YIHCF has a market cap of 1.49B. Regarding current trading prices, CANB is priced at $0.03, while YIHCF trades at $0.55.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
CANB currently has a P/E ratio of 0.35, whereas YIHCF's P/E ratio is -5.00. In terms of profitability, CANB's ROE is +2.20%, compared to YIHCF's ROE of +0.19%. Regarding short-term risk, CANB is more volatile compared to YIHCF. This indicates potentially higher risk in terms of short-term price fluctuations for CANB.
CANB vs EVOTF Comparison
CANB plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, CANB stands at 2.37M. In comparison, EVOTF has a market cap of 1.47B. Regarding current trading prices, CANB is priced at $0.03, while EVOTF trades at $8.27.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
CANB currently has a P/E ratio of 0.35, whereas EVOTF's P/E ratio is -7.52. In terms of profitability, CANB's ROE is +2.20%, compared to EVOTF's ROE of -0.22%. Regarding short-term risk, CANB is less volatile compared to EVOTF. This indicates potentially lower risk in terms of short-term price fluctuations for CANB.
CANB vs ARSUF Comparison
CANB plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, CANB stands at 2.37M. In comparison, ARSUF has a market cap of 1.46B. Regarding current trading prices, CANB is priced at $0.03, while ARSUF trades at $20.03.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
CANB currently has a P/E ratio of 0.35, whereas ARSUF's P/E ratio is 18.05. In terms of profitability, CANB's ROE is +2.20%, compared to ARSUF's ROE of +0.16%. Regarding short-term risk, CANB is more volatile compared to ARSUF. This indicates potentially higher risk in terms of short-term price fluctuations for CANB.
CANB vs SWGHF Comparison
CANB plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, CANB stands at 2.37M. In comparison, SWGHF has a market cap of 1.33B. Regarding current trading prices, CANB is priced at $0.03, while SWGHF trades at $11.52.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
CANB currently has a P/E ratio of 0.35, whereas SWGHF's P/E ratio is 15.78. In terms of profitability, CANB's ROE is +2.20%, compared to SWGHF's ROE of +0.10%. Regarding short-term risk, CANB is more volatile compared to SWGHF. This indicates potentially higher risk in terms of short-term price fluctuations for CANB.
CANB vs GTBIF Comparison
CANB plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, CANB stands at 2.37M. In comparison, GTBIF has a market cap of 1.32B. Regarding current trading prices, CANB is priced at $0.03, while GTBIF trades at $5.55.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
CANB currently has a P/E ratio of 0.35, whereas GTBIF's P/E ratio is 26.43. In terms of profitability, CANB's ROE is +2.20%, compared to GTBIF's ROE of +0.03%. Regarding short-term risk, CANB is more volatile compared to GTBIF. This indicates potentially higher risk in terms of short-term price fluctuations for CANB.
CANB vs GNMLF Comparison
CANB plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, CANB stands at 2.37M. In comparison, GNMLF has a market cap of 1.09B. Regarding current trading prices, CANB is priced at $0.03, while GNMLF trades at $1.09.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
CANB currently has a P/E ratio of 0.35, whereas GNMLF's P/E ratio is 9.91. In terms of profitability, CANB's ROE is +2.20%, compared to GNMLF's ROE of +0.12%. Regarding short-term risk, CANB is more volatile compared to GNMLF. This indicates potentially higher risk in terms of short-term price fluctuations for CANB.
CANB vs KKPCF Comparison
CANB plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, CANB stands at 2.37M. In comparison, KKPCF has a market cap of 1.03B. Regarding current trading prices, CANB is priced at $0.03, while KKPCF trades at $26.78.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
CANB currently has a P/E ratio of 0.35, whereas KKPCF's P/E ratio is 10.76. In terms of profitability, CANB's ROE is +2.20%, compared to KKPCF's ROE of +0.04%. Regarding short-term risk, CANB is more volatile compared to KKPCF. This indicates potentially higher risk in terms of short-term price fluctuations for CANB.
CANB vs KSPHF Comparison
CANB plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, CANB stands at 2.37M. In comparison, KSPHF has a market cap of 994.32M. Regarding current trading prices, CANB is priced at $0.03, while KSPHF trades at $23.23.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
CANB currently has a P/E ratio of 0.35, whereas KSPHF's P/E ratio is 12.29. In terms of profitability, CANB's ROE is +2.20%, compared to KSPHF's ROE of +0.05%. Regarding short-term risk, CANB is more volatile compared to KSPHF. This indicates potentially higher risk in terms of short-term price fluctuations for CANB.
CANB vs CASBF Comparison
CANB plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, CANB stands at 2.37M. In comparison, CASBF has a market cap of 976.38M. Regarding current trading prices, CANB is priced at $0.03, while CASBF trades at $3.20.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
CANB currently has a P/E ratio of 0.35, whereas CASBF's P/E ratio is -15.24. In terms of profitability, CANB's ROE is +2.20%, compared to CASBF's ROE of -0.14%. Regarding short-term risk, CANB is less volatile compared to CASBF. This indicates potentially lower risk in terms of short-term price fluctuations for CANB.
CANB vs SHPHF Comparison
CANB plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, CANB stands at 2.37M. In comparison, SHPHF has a market cap of 924.41M. Regarding current trading prices, CANB is priced at $0.03, while SHPHF trades at $0.10.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
CANB currently has a P/E ratio of 0.35, whereas SHPHF's P/E ratio is -3.33. In terms of profitability, CANB's ROE is +2.20%, compared to SHPHF's ROE of -0.01%. Regarding short-term risk, CANB is less volatile compared to SHPHF. This indicates potentially lower risk in terms of short-term price fluctuations for CANB.
CANB vs BIOGY Comparison
CANB plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, CANB stands at 2.37M. In comparison, BIOGY has a market cap of 905.20M. Regarding current trading prices, CANB is priced at $0.03, while BIOGY trades at $9.29.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
CANB currently has a P/E ratio of 0.35, whereas BIOGY's P/E ratio is 29.96. In terms of profitability, CANB's ROE is +2.20%, compared to BIOGY's ROE of +0.18%. Regarding short-term risk, CANB is more volatile compared to BIOGY. This indicates potentially higher risk in terms of short-term price fluctuations for CANB.
CANB vs LVTTF Comparison
CANB plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, CANB stands at 2.37M. In comparison, LVTTF has a market cap of 881.66M. Regarding current trading prices, CANB is priced at $0.03, while LVTTF trades at $0.00.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
CANB currently has a P/E ratio of 0.35, whereas LVTTF's P/E ratio is -0.02. In terms of profitability, CANB's ROE is +2.20%, compared to LVTTF's ROE of +0.00%. Regarding short-term risk, CANB is less volatile compared to LVTTF. This indicates potentially lower risk in terms of short-term price fluctuations for CANB.
CANB vs EVRRF Comparison
CANB plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, CANB stands at 2.37M. In comparison, EVRRF has a market cap of 877.86M. Regarding current trading prices, CANB is priced at $0.03, while EVRRF trades at $0.00.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
CANB currently has a P/E ratio of 0.35, whereas EVRRF's P/E ratio is -0.08. In terms of profitability, CANB's ROE is +2.20%, compared to EVRRF's ROE of +2.97%. Regarding short-term risk, CANB is more volatile compared to EVRRF. This indicates potentially higher risk in terms of short-term price fluctuations for CANB.
CANB vs NRXCF Comparison
CANB plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, CANB stands at 2.37M. In comparison, NRXCF has a market cap of 832.96M. Regarding current trading prices, CANB is priced at $0.03, while NRXCF trades at $0.00.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
CANB currently has a P/E ratio of 0.35, whereas NRXCF's P/E ratio is -0.22. In terms of profitability, CANB's ROE is +2.20%, compared to NRXCF's ROE of +2.32%. Regarding short-term risk, CANB is more volatile compared to NRXCF. This indicates potentially higher risk in terms of short-term price fluctuations for CANB.
CANB vs TWAPF Comparison
CANB plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, CANB stands at 2.37M. In comparison, TWAPF has a market cap of 828.49M. Regarding current trading prices, CANB is priced at $0.03, while TWAPF trades at $16.83.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
CANB currently has a P/E ratio of 0.35, whereas TWAPF's P/E ratio is 6.35. In terms of profitability, CANB's ROE is +2.20%, compared to TWAPF's ROE of +0.09%. Regarding short-term risk, CANB is more volatile compared to TWAPF. This indicates potentially higher risk in terms of short-term price fluctuations for CANB.
CANB vs TCNNF Comparison
CANB plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, CANB stands at 2.37M. In comparison, TCNNF has a market cap of 815.90M. Regarding current trading prices, CANB is priced at $0.03, while TCNNF trades at $4.27.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
CANB currently has a P/E ratio of 0.35, whereas TCNNF's P/E ratio is -5.41. In terms of profitability, CANB's ROE is +2.20%, compared to TCNNF's ROE of -0.13%. Regarding short-term risk, CANB is more volatile compared to TCNNF. This indicates potentially higher risk in terms of short-term price fluctuations for CANB.
CANB vs CSWYF Comparison
CANB plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, CANB stands at 2.37M. In comparison, CSWYF has a market cap of 815.83M. Regarding current trading prices, CANB is priced at $0.03, while CSWYF trades at $1.08.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
CANB currently has a P/E ratio of 0.35, whereas CSWYF's P/E ratio is 5.14. In terms of profitability, CANB's ROE is +2.20%, compared to CSWYF's ROE of +0.07%. Regarding short-term risk, CANB is more volatile compared to CSWYF. This indicates potentially higher risk in terms of short-term price fluctuations for CANB.
CANB vs TRXPF Comparison
CANB plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, CANB stands at 2.37M. In comparison, TRXPF has a market cap of 690.69M. Regarding current trading prices, CANB is priced at $0.03, while TRXPF trades at $24.57.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
CANB currently has a P/E ratio of 0.35, whereas TRXPF's P/E ratio is 25.86. In terms of profitability, CANB's ROE is +2.20%, compared to TRXPF's ROE of +0.04%. Regarding short-term risk, CANB is more volatile compared to TRXPF. This indicates potentially higher risk in terms of short-term price fluctuations for CANB.
CANB vs SWDCF Comparison
CANB plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, CANB stands at 2.37M. In comparison, SWDCF has a market cap of 679.32M. Regarding current trading prices, CANB is priced at $0.03, while SWDCF trades at $4.25.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
CANB currently has a P/E ratio of 0.35, whereas SWDCF's P/E ratio is 70.83. In terms of profitability, CANB's ROE is +2.20%, compared to SWDCF's ROE of +0.01%. Regarding short-term risk, CANB is more volatile compared to SWDCF. This indicates potentially higher risk in terms of short-term price fluctuations for CANB.
CANB vs NIKA Comparison
CANB plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, CANB stands at 2.37M. In comparison, NIKA has a market cap of 672.85M. Regarding current trading prices, CANB is priced at $0.03, while NIKA trades at $0.66.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
CANB currently has a P/E ratio of 0.35, whereas NIKA's P/E ratio is N/A. In terms of profitability, CANB's ROE is +2.20%, compared to NIKA's ROE of +0.39%. Regarding short-term risk, CANB is less volatile compared to NIKA. This indicates potentially lower risk in terms of short-term price fluctuations for CANB.
CANB vs CURLF Comparison
CANB plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, CANB stands at 2.37M. In comparison, CURLF has a market cap of 650.56M. Regarding current trading prices, CANB is priced at $0.03, while CURLF trades at $0.86.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
CANB currently has a P/E ratio of 0.35, whereas CURLF's P/E ratio is -2.61. In terms of profitability, CANB's ROE is +2.20%, compared to CURLF's ROE of -0.25%. Regarding short-term risk, CANB is less volatile compared to CURLF. This indicates potentially lower risk in terms of short-term price fluctuations for CANB.
CANB vs TRSSF Comparison
CANB plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, CANB stands at 2.37M. In comparison, TRSSF has a market cap of 601.91M. Regarding current trading prices, CANB is priced at $0.03, while TRSSF trades at $1.72.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
CANB currently has a P/E ratio of 0.35, whereas TRSSF's P/E ratio is -1.32. In terms of profitability, CANB's ROE is +2.20%, compared to TRSSF's ROE of -0.32%. Regarding short-term risk, CANB is less volatile compared to TRSSF. This indicates potentially lower risk in terms of short-term price fluctuations for CANB.
CANB vs ELTP Comparison
CANB plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, CANB stands at 2.37M. In comparison, ELTP has a market cap of 544.71M. Regarding current trading prices, CANB is priced at $0.03, while ELTP trades at $0.51.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
CANB currently has a P/E ratio of 0.35, whereas ELTP's P/E ratio is -25.49. In terms of profitability, CANB's ROE is +2.20%, compared to ELTP's ROE of -0.36%. Regarding short-term risk, CANB is more volatile compared to ELTP. This indicates potentially higher risk in terms of short-term price fluctuations for CANB.
CANB vs SGFEF Comparison
CANB plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, CANB stands at 2.37M. In comparison, SGFEF has a market cap of 524.72M. Regarding current trading prices, CANB is priced at $0.03, while SGFEF trades at $102.50.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
CANB currently has a P/E ratio of 0.35, whereas SGFEF's P/E ratio is 23.19. In terms of profitability, CANB's ROE is +2.20%, compared to SGFEF's ROE of +0.11%. Regarding short-term risk, CANB is less volatile compared to SGFEF. This indicates potentially lower risk in terms of short-term price fluctuations for CANB.
CANB vs CCHWF Comparison
CANB plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, CANB stands at 2.37M. In comparison, CCHWF has a market cap of 521.35M. Regarding current trading prices, CANB is priced at $0.03, while CCHWF trades at $0.94.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
CANB currently has a P/E ratio of 0.35, whereas CCHWF's P/E ratio is -1.12. In terms of profitability, CANB's ROE is +2.20%, compared to CCHWF's ROE of -7.05%. Regarding short-term risk, CANB is less volatile compared to CCHWF. This indicates potentially lower risk in terms of short-term price fluctuations for CANB.
CANB vs AIHLF Comparison
CANB plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, CANB stands at 2.37M. In comparison, AIHLF has a market cap of 507.80M. Regarding current trading prices, CANB is priced at $0.03, while AIHLF trades at $3.14.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
CANB currently has a P/E ratio of 0.35, whereas AIHLF's P/E ratio is 10.83. In terms of profitability, CANB's ROE is +2.20%, compared to AIHLF's ROE of +0.15%. Regarding short-term risk, CANB is less volatile compared to AIHLF. This indicates potentially lower risk in terms of short-term price fluctuations for CANB.
CANB vs BOIRF Comparison
CANB plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, CANB stands at 2.37M. In comparison, BOIRF has a market cap of 494.82M. Regarding current trading prices, CANB is priced at $0.03, while BOIRF trades at $28.50.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
CANB currently has a P/E ratio of 0.35, whereas BOIRF's P/E ratio is 20.07. In terms of profitability, CANB's ROE is +2.20%, compared to BOIRF's ROE of +0.06%. Regarding short-term risk, CANB is less volatile compared to BOIRF. This indicates potentially lower risk in terms of short-term price fluctuations for CANB.
CANB vs PEXXF Comparison
CANB plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, CANB stands at 2.37M. In comparison, PEXXF has a market cap of 463.12M. Regarding current trading prices, CANB is priced at $0.03, while PEXXF trades at $0.09.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
CANB currently has a P/E ratio of 0.35, whereas PEXXF's P/E ratio is 9.00. In terms of profitability, CANB's ROE is +2.20%, compared to PEXXF's ROE of N/A. Regarding short-term risk, CANB is more volatile compared to PEXXF. This indicates potentially higher risk in terms of short-term price fluctuations for CANB.
CANB vs MITPF Comparison
CANB plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, CANB stands at 2.37M. In comparison, MITPF has a market cap of 451.63M. Regarding current trading prices, CANB is priced at $0.03, while MITPF trades at $6.75.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
CANB currently has a P/E ratio of 0.35, whereas MITPF's P/E ratio is -3.05. In terms of profitability, CANB's ROE is +2.20%, compared to MITPF's ROE of +4.92%. Regarding short-term risk, CANB is more volatile compared to MITPF. This indicates potentially higher risk in terms of short-term price fluctuations for CANB.
CANB vs KHTRF Comparison
CANB plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, CANB stands at 2.37M. In comparison, KHTRF has a market cap of 444.34M. Regarding current trading prices, CANB is priced at $0.03, while KHTRF trades at $4.46.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
CANB currently has a P/E ratio of 0.35, whereas KHTRF's P/E ratio is 63.71. In terms of profitability, CANB's ROE is +2.20%, compared to KHTRF's ROE of +0.01%. Regarding short-term risk, CANB is more volatile compared to KHTRF. This indicates potentially higher risk in terms of short-term price fluctuations for CANB.
CANB vs CNGGF Comparison
CANB plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, CANB stands at 2.37M. In comparison, CNGGF has a market cap of 419.23M. Regarding current trading prices, CANB is priced at $0.03, while CNGGF trades at $0.01.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
CANB currently has a P/E ratio of 0.35, whereas CNGGF's P/E ratio is -0.10. In terms of profitability, CANB's ROE is +2.20%, compared to CNGGF's ROE of -1.60%. Regarding short-term risk, CANB is less volatile compared to CNGGF. This indicates potentially lower risk in terms of short-term price fluctuations for CANB.
CANB vs AGYTF Comparison
CANB plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, CANB stands at 2.37M. In comparison, AGYTF has a market cap of 405.15M. Regarding current trading prices, CANB is priced at $0.03, while AGYTF trades at $0.09.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
CANB currently has a P/E ratio of 0.35, whereas AGYTF's P/E ratio is -8.50. In terms of profitability, CANB's ROE is +2.20%, compared to AGYTF's ROE of -2.67%. Regarding short-term risk, CANB is less volatile compared to AGYTF. This indicates potentially lower risk in terms of short-term price fluctuations for CANB.
CANB vs GLASF Comparison
CANB plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, CANB stands at 2.37M. In comparison, GLASF has a market cap of 308.14M. Regarding current trading prices, CANB is priced at $0.03, while GLASF trades at $6.22.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
CANB currently has a P/E ratio of 0.35, whereas GLASF's P/E ratio is -69.06. In terms of profitability, CANB's ROE is +2.20%, compared to GLASF's ROE of +0.00%. Regarding short-term risk, CANB is more volatile compared to GLASF. This indicates potentially higher risk in terms of short-term price fluctuations for CANB.
CANB vs PKBFF Comparison
CANB plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, CANB stands at 2.37M. In comparison, PKBFF has a market cap of 285.89M. Regarding current trading prices, CANB is priced at $0.03, while PKBFF trades at $0.00.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
CANB currently has a P/E ratio of 0.35, whereas PKBFF's P/E ratio is -0.00. In terms of profitability, CANB's ROE is +2.20%, compared to PKBFF's ROE of +7.96%. Regarding short-term risk, CANB is less volatile compared to PKBFF. This indicates potentially lower risk in terms of short-term price fluctuations for CANB.
CANB vs BHCCF Comparison
CANB plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, CANB stands at 2.37M. In comparison, BHCCF has a market cap of 271.24M. Regarding current trading prices, CANB is priced at $0.03, while BHCCF trades at $0.37.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
CANB currently has a P/E ratio of 0.35, whereas BHCCF's P/E ratio is -4.57. In terms of profitability, CANB's ROE is +2.20%, compared to BHCCF's ROE of -0.18%. Regarding short-term risk, CANB is less volatile compared to BHCCF. This indicates potentially lower risk in terms of short-term price fluctuations for CANB.
CANB vs VRNOF Comparison
CANB plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, CANB stands at 2.37M. In comparison, VRNOF has a market cap of 244.93M. Regarding current trading prices, CANB is priced at $0.03, while VRNOF trades at $0.68.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
CANB currently has a P/E ratio of 0.35, whereas VRNOF's P/E ratio is -0.68. In terms of profitability, CANB's ROE is +2.20%, compared to VRNOF's ROE of -0.22%. Regarding short-term risk, CANB is more volatile compared to VRNOF. This indicates potentially higher risk in terms of short-term price fluctuations for CANB.
CANB vs CRLBF Comparison
CANB plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, CANB stands at 2.37M. In comparison, CRLBF has a market cap of 230.37M. Regarding current trading prices, CANB is priced at $0.03, while CRLBF trades at $0.68.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
CANB currently has a P/E ratio of 0.35, whereas CRLBF's P/E ratio is -3.11. In terms of profitability, CANB's ROE is +2.20%, compared to CRLBF's ROE of -0.16%. Regarding short-term risk, CANB is less volatile compared to CRLBF. This indicates potentially lower risk in terms of short-term price fluctuations for CANB.
CANB vs CPHRF Comparison
CANB plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, CANB stands at 2.37M. In comparison, CPHRF has a market cap of 223.85M. Regarding current trading prices, CANB is priced at $0.03, while CPHRF trades at $8.74.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
CANB currently has a P/E ratio of 0.35, whereas CPHRF's P/E ratio is 19.00. In terms of profitability, CANB's ROE is +2.20%, compared to CPHRF's ROE of +0.09%. Regarding short-term risk, CANB is more volatile compared to CPHRF. This indicates potentially higher risk in terms of short-term price fluctuations for CANB.
CANB vs PLNHF Comparison
CANB plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, CANB stands at 2.37M. In comparison, PLNHF has a market cap of 202.02M. Regarding current trading prices, CANB is priced at $0.03, while PLNHF trades at $0.91.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
CANB currently has a P/E ratio of 0.35, whereas PLNHF's P/E ratio is -3.50. In terms of profitability, CANB's ROE is +2.20%, compared to PLNHF's ROE of -0.34%. Regarding short-term risk, CANB is less volatile compared to PLNHF. This indicates potentially lower risk in terms of short-term price fluctuations for CANB.
CANB vs HUMDF Comparison
CANB plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, CANB stands at 2.37M. In comparison, HUMDF has a market cap of 147.55M. Regarding current trading prices, CANB is priced at $0.03, while HUMDF trades at $0.15.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
CANB currently has a P/E ratio of 0.35, whereas HUMDF's P/E ratio is -3.75. In terms of profitability, CANB's ROE is +2.20%, compared to HUMDF's ROE of +8.06%. Regarding short-term risk, CANB is more volatile compared to HUMDF. This indicates potentially higher risk in terms of short-term price fluctuations for CANB.
CANB vs COPHF Comparison
CANB plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, CANB stands at 2.37M. In comparison, COPHF has a market cap of 131.72M. Regarding current trading prices, CANB is priced at $0.03, while COPHF trades at $0.12.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
CANB currently has a P/E ratio of 0.35, whereas COPHF's P/E ratio is -0.02. In terms of profitability, CANB's ROE is +2.20%, compared to COPHF's ROE of -5.75%. Regarding short-term risk, CANB is less volatile compared to COPHF. This indicates potentially lower risk in terms of short-term price fluctuations for CANB.
CANB vs STMH Comparison
CANB plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, CANB stands at 2.37M. In comparison, STMH has a market cap of 123.98M. Regarding current trading prices, CANB is priced at $0.03, while STMH trades at $0.00.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
CANB currently has a P/E ratio of 0.35, whereas STMH's P/E ratio is N/A. In terms of profitability, CANB's ROE is +2.20%, compared to STMH's ROE of -2.75%. Regarding short-term risk, CANB is less volatile compared to STMH. This indicates potentially lower risk in terms of short-term price fluctuations for CANB.
CANB vs PHCUF Comparison
CANB plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, CANB stands at 2.37M. In comparison, PHCUF has a market cap of 115.12M. Regarding current trading prices, CANB is priced at $0.03, while PHCUF trades at $4.32.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
CANB currently has a P/E ratio of 0.35, whereas PHCUF's P/E ratio is 432.00. In terms of profitability, CANB's ROE is +2.20%, compared to PHCUF's ROE of +0.00%. Regarding short-term risk, CANB is more volatile compared to PHCUF. This indicates potentially higher risk in terms of short-term price fluctuations for CANB.
CANB vs LPCUF Comparison
CANB plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, CANB stands at 2.37M. In comparison, LPCUF has a market cap of 110.82M. Regarding current trading prices, CANB is priced at $0.03, while LPCUF trades at $0.19.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
CANB currently has a P/E ratio of 0.35, whereas LPCUF's P/E ratio is 18.82. In terms of profitability, CANB's ROE is +2.20%, compared to LPCUF's ROE of +0.05%. Regarding short-term risk, CANB is more volatile compared to LPCUF. This indicates potentially higher risk in terms of short-term price fluctuations for CANB.
CANB vs CNVCF Comparison
CANB plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, CANB stands at 2.37M. In comparison, CNVCF has a market cap of 109.16M. Regarding current trading prices, CANB is priced at $0.03, while CNVCF trades at $6.30.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
CANB currently has a P/E ratio of 0.35, whereas CNVCF's P/E ratio is -5.00. In terms of profitability, CANB's ROE is +2.20%, compared to CNVCF's ROE of +9.56%. Regarding short-term risk, CANB is more volatile compared to CNVCF. This indicates potentially higher risk in terms of short-term price fluctuations for CANB.
CANB vs HLTRF Comparison
CANB plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, CANB stands at 2.37M. In comparison, HLTRF has a market cap of 102.37M. Regarding current trading prices, CANB is priced at $0.03, while HLTRF trades at $3.22.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
CANB currently has a P/E ratio of 0.35, whereas HLTRF's P/E ratio is -5.65. In terms of profitability, CANB's ROE is +2.20%, compared to HLTRF's ROE of -0.24%. Regarding short-term risk, CANB is more volatile compared to HLTRF. This indicates potentially higher risk in terms of short-term price fluctuations for CANB.
CANB vs BIOYF Comparison
CANB plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, CANB stands at 2.37M. In comparison, BIOYF has a market cap of 97.27M. Regarding current trading prices, CANB is priced at $0.03, while BIOYF trades at $8.48.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
CANB currently has a P/E ratio of 0.35, whereas BIOYF's P/E ratio is 17.67. In terms of profitability, CANB's ROE is +2.20%, compared to BIOYF's ROE of +0.20%. Regarding short-term risk, CANB is more volatile compared to BIOYF. This indicates potentially higher risk in terms of short-term price fluctuations for CANB.
CANB vs GRUSF Comparison
CANB plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, CANB stands at 2.37M. In comparison, GRUSF has a market cap of 96.66M. Regarding current trading prices, CANB is priced at $0.03, while GRUSF trades at $0.39.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
CANB currently has a P/E ratio of 0.35, whereas GRUSF's P/E ratio is -7.80. In terms of profitability, CANB's ROE is +2.20%, compared to GRUSF's ROE of -0.89%. Regarding short-term risk, CANB is more volatile compared to GRUSF. This indicates potentially higher risk in terms of short-term price fluctuations for CANB.
CANB vs ABSCF Comparison
CANB plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, CANB stands at 2.37M. In comparison, ABSCF has a market cap of 92.53M. Regarding current trading prices, CANB is priced at $0.03, while ABSCF trades at $1.60.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
CANB currently has a P/E ratio of 0.35, whereas ABSCF's P/E ratio is -9.41. In terms of profitability, CANB's ROE is +2.20%, compared to ABSCF's ROE of +0.26%. Regarding short-term risk, CANB is less volatile compared to ABSCF. This indicates potentially lower risk in terms of short-term price fluctuations for CANB.
CANB vs LOVFF Comparison
CANB plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, CANB stands at 2.37M. In comparison, LOVFF has a market cap of 83.95M. Regarding current trading prices, CANB is priced at $0.03, while LOVFF trades at $0.92.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
CANB currently has a P/E ratio of 0.35, whereas LOVFF's P/E ratio is 9.18. In terms of profitability, CANB's ROE is +2.20%, compared to LOVFF's ROE of +0.15%. Regarding short-term risk, CANB is more volatile compared to LOVFF. This indicates potentially higher risk in terms of short-term price fluctuations for CANB.
CANB vs GBLP Comparison
CANB plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, CANB stands at 2.37M. In comparison, GBLP has a market cap of 83.54M. Regarding current trading prices, CANB is priced at $0.03, while GBLP trades at $0.20.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
CANB currently has a P/E ratio of 0.35, whereas GBLP's P/E ratio is -0.67. In terms of profitability, CANB's ROE is +2.20%, compared to GBLP's ROE of +0.31%. Regarding short-term risk, CANB is less volatile compared to GBLP. This indicates potentially lower risk in terms of short-term price fluctuations for CANB.
CANB vs LRDSF Comparison
CANB plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, CANB stands at 2.37M. In comparison, LRDSF has a market cap of 82.80M. Regarding current trading prices, CANB is priced at $0.03, while LRDSF trades at $0.00.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
CANB currently has a P/E ratio of 0.35, whereas LRDSF's P/E ratio is -0.01. In terms of profitability, CANB's ROE is +2.20%, compared to LRDSF's ROE of +1.61%. Regarding short-term risk, CANB is less volatile compared to LRDSF. This indicates potentially lower risk in terms of short-term price fluctuations for CANB.
CANB vs CBWTF Comparison
CANB plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, CANB stands at 2.37M. In comparison, CBWTF has a market cap of 81.47M. Regarding current trading prices, CANB is priced at $0.03, while CBWTF trades at $0.06.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
CANB currently has a P/E ratio of 0.35, whereas CBWTF's P/E ratio is -6.20. In terms of profitability, CANB's ROE is +2.20%, compared to CBWTF's ROE of -0.15%. Regarding short-term risk, CANB is more volatile compared to CBWTF. This indicates potentially higher risk in terms of short-term price fluctuations for CANB.
CANB vs PLNH Comparison
CANB plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, CANB stands at 2.37M. In comparison, PLNH has a market cap of 78.17M. Regarding current trading prices, CANB is priced at $0.03, while PLNH trades at $0.24.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
CANB currently has a P/E ratio of 0.35, whereas PLNH's P/E ratio is -1.41. In terms of profitability, CANB's ROE is +2.20%, compared to PLNH's ROE of -0.32%. Regarding short-term risk, CANB is more volatile compared to PLNH. This indicates potentially higher risk in terms of short-term price fluctuations for CANB.
CANB vs EOFBY Comparison
CANB plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, CANB stands at 2.37M. In comparison, EOFBY has a market cap of 73.67M. Regarding current trading prices, CANB is priced at $0.03, while EOFBY trades at $0.84.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
CANB currently has a P/E ratio of 0.35, whereas EOFBY's P/E ratio is -7.67. In terms of profitability, CANB's ROE is +2.20%, compared to EOFBY's ROE of N/A. Regarding short-term risk, CANB is more volatile compared to EOFBY. This indicates potentially higher risk in terms of short-term price fluctuations for CANB.
CANB vs JUSHF Comparison
CANB plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, CANB stands at 2.37M. In comparison, JUSHF has a market cap of 64.91M. Regarding current trading prices, CANB is priced at $0.03, while JUSHF trades at $0.33.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
CANB currently has a P/E ratio of 0.35, whereas JUSHF's P/E ratio is -1.32. In terms of profitability, CANB's ROE is +2.20%, compared to JUSHF's ROE of +1.06%. Regarding short-term risk, CANB is more volatile compared to JUSHF. This indicates potentially higher risk in terms of short-term price fluctuations for CANB.